There are 150 resources available
Scientific Part: Novel Predictive Biomarkers for Treatment in Lower GI Cancers
Presenter: Noelia Tarazona, Spain
Session: Session IV: ESMO Session: Focus on Young Oncologists (YO) in Collaboration With ESMO Young Oncologist Committee (YOC)
Resources:
Slides
Discussant: SO-4, SO-5, SO-6
Presenter: Karin Haustermans, Belgium
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Scientific Part: Q&A and Panel Discussion
Presenter: Claudia Cardone, Italy; Andrés Cervantes, Spain; Elene Mariamidze, Georgia; Rille Pihlak, United Kingdom; Elizabeth Smyth, United Kingdom; Noelia Tarazona, Spain
Session: Session IV: ESMO Session: Focus on Young Oncologists (YO) in Collaboration With ESMO Young Oncologist Committee (YOC)
Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): expanded efficacy and safety analyses from CheckMate 648
Presenter: Ian Chau, United Kingdom
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Mentorship Part: What a Successful Career in GI Oncology Looks Like
Presenter: Chiara Cremolini, Italy
Session: Session IV: ESMO Session: Focus on Young Oncologists (YO) in Collaboration With ESMO Young Oncologist Committee (YOC)
Resources:
Slides
Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophagogastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)
Presenter: Per Pfeiffer, Denmark
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Co-occurring HER2 and PD-L1 expression in patients with HER2-positive trastuzumab-refractory gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): biomarker analysis from the trastuzumab deruxtecan (T-DXd) DESTINY-Gastric03 trial
Presenter: Yelena Janjigian, United States
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Mentorship Part: Writing Your First Grant Application
Presenter: Joaquin Mateo, Spain
Session: Session IV: ESMO Session: Focus on Young Oncologists (YO) in Collaboration With ESMO Young Oncologist Committee (YOC)
Resources:
Slides
Soluble programmed cell death ligand 1 associated with clinical outcome in gastric cancer patients treated with nivolumab: Blood based biomarker analysis of DELIVER trial (JACCRO-GC08AR)
Presenter: Hisato Kawakami, Japan
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides
Discussant: O-3, O-4, SO-7, SO-8
Presenter: Kei Muro, Japan
Session: Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Resources:
Slides